Roots-Analysis-Logo.png
The market for 3D cell culture products is estimated to be worth USD 6.8 Billion by 2030, growing at an annualized rate of over 15.5%, claims Roots Analysis
24 nov. 2020 08h30 HE | Roots Analysis
London, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “3D Cell Culture Market” report to its list of offerings. Over the years, various industry stakeholders...
PositiveID Corporati
PositiveID Corporation Comments on Department of Homeland Security's Revised Procurement Strategy for BioWatch Generation 3, Phase II
24 sept. 2012 16h05 HE | PositiveID Corporation
Updated Strategy Consists of a Two-Stage Procurement, the First Stage of Which is Planned to Begin Later This Year With the Release of Draft Request for Proposal Company Believes it is Well...
PositiveID Corporati
PositiveID Corporation Adds Chief Technology Advisor and Biodefense Expert as It Prepares for $3.1 Billion BioWatch Procurement
25 juil. 2012 08h30 HE | PositiveID Corporation
DELRAY BEACH, Fla., July 25, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of sophisticated airborne bio-threat...
PositiveID Corporati
PositiveID Corporation's M-BAND System Featured in Businessweek Article on $5.7 Billion BioWatch Opportunity
25 juin 2012 08h30 HE | PositiveID Corporation
DELRAY BEACH, Fla., June 25, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of sophisticated airborne bio-threat...
PositiveID Corporati
PositiveID Corporation Receives an Additional Key Patent for Fieldable Biological Detection
02 août 2011 16h30 HE | PositiveID Corporation
DELRAY BEACH, Fla., Aug. 2, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical diagnostics...